- |||||||||| Phase classification: LeucoPatch (clinicaltrials.gov) - Apr 24, 2023
P=N/A, N=60, Completed, Phase classification: P4 --> P=N/A
- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Potential Research Study Participant Registry (clinicaltrials.gov) - Feb 16, 2019
P=N/A, N=265, Completed, Recruiting --> Completed | N=30 --> 13 Recruiting --> Completed | N=200 --> 265 | Trial completion date: Jan 2025 --> Sep 2018 | Trial primary completion date: Jan 2025 --> Sep 2018
- |||||||||| NN1213 / Novo Nordisk
Enrollment change, Trial withdrawal: ADA NPWT: Negative Pressure Wound Therapy as a Drug Delivery System (ADANPWT) (clinicaltrials.gov) - Jan 22, 2019 P=N/A, N=0, Withdrawn, Recruiting --> Completed | N=200 --> 265 | Trial completion date: Jan 2025 --> Sep 2018 | Trial primary completion date: Jan 2025 --> Sep 2018 N=150 --> 0 | Recruiting --> Withdrawn
- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds (clinicaltrials.gov) - Aug 31, 2018 P2, N=111, Completed, Recruiting --> Completed | Trial completion date: Oct 2017 --> Jun 2018 | Trial primary completion date: May 2017 --> Jun 2018 Recruiting --> Completed | Trial completion date: Jun 2017 --> Jun 2018 | Trial primary completion date: Mar 2017 --> Dec 2017
- |||||||||| NN1213 / Novo Nordisk
Trial completion, Trial completion date: Use of dHACM in the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Aug 24, 2018 P=N/A, N=128, Completed, Recruiting --> Completed | Trial completion date: Jun 2017 --> Jun 2018 | Trial primary completion date: Mar 2017 --> Dec 2017 Active, not recruiting --> Completed | Trial completion date: Jul 2017 --> Nov 2017
- |||||||||| Enrollment change, Trial termination: SAS-FOOT: Impact of Sleep Apnea on Diabetic Foot Wound. (clinicaltrials.gov) - Jun 28, 2018
P=N/A, N=35, Terminated, Trial completion date: Mar 2019 --> Mar 2020 | Trial primary completion date: Mar 2019 --> Mar 2020 N=60 --> 35 | Recruiting --> Terminated; Difficulty including subjects corresponding to the criteria.
- |||||||||| Enrollment change, Trial initiation date, Trial termination, Trial primary completion date: STRIDE 5: Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use (clinicaltrials.gov) - Dec 12, 2017
P3, N=261, Terminated, N=633 --> 396 | Active, not recruiting --> Terminated | Trial primary completion date: Mar 2016 --> Dec 2015 N=200 --> 261 | Initiation date: Jun 2013 --> Dec 2015 | Active, not recruiting --> Terminated | Trial primary completion date: Jun 2016 --> Dec 2015
- |||||||||| Enrollment closed: LeucoPatch in the Management of Hard-to-heal Diabetic Foot Ulcers (clinicaltrials.gov) - Dec 7, 2017
P4, N=269, Active, not recruiting, N=200 --> 261 | Initiation date: Jun 2013 --> Dec 2015 | Active, not recruiting --> Terminated | Trial primary completion date: Jun 2016 --> Dec 2015 Recruiting --> Active, not recruiting
- |||||||||| Trial completion: ADHOC: The Sorbact (clinicaltrials.gov) - Aug 31, 2017
P3, N=200, Completed, Active, not recruiting --> Completed | Trial primary completion date: Mar 2017 --> Jul 2017 Active, not recruiting --> Completed
- |||||||||| Phase classification, Enrollment change, Trial primary completion date: Treatment of the Hypertensive Leg Ulcers by PRF Application (clinicaltrials.gov) - Jul 2, 2017
P4, N=10, Terminated, Active, not recruiting --> Completed | N=250 --> 155 | Trial primary completion date: Apr 2015 --> Nov 2015 Phase classification: P2 --> P4 | N=18 --> 10 | Trial primary completion date: Jul 2015 --> Jul 2017
- |||||||||| aspirin / Generic mfg.
Trial termination: Aspirin for Venous Ulcers: Randomised Trial (AVURT) (clinicaltrials.gov) - Jun 27, 2017 P2, N=26, Terminated, Active, not recruiting --> Terminated; Recruitment halted following TSC meeting due to poor recruitment and study unlikely to complete. Funders withdrew continued support
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: CONDUCT I: NEOX (clinicaltrials.gov) - Jun 27, 2017
P=N/A, N=18, Terminated, Funders withdrew continued support N=30 --> 18 | Recruiting --> Terminated | Trial primary completion date: Jun 2016 --> Jun 2015; Sponsor decision
- |||||||||| Trial completion, Trial primary completion date: ORTHODIAB: Evaluation of a New Device "Orth (clinicaltrials.gov) - Jun 1, 2017
P=N/A, N=118, Completed, Active, not recruiting --> Completed | N=440 --> 221 | Trial primary completion date: Feb 2016 --> Nov 2015 Recruiting --> Completed | Trial primary completion date: May 2016 --> Nov 2016
- |||||||||| Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date: A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro (clinicaltrials.gov) - May 30, 2017
P2/3, N=0, Withdrawn, Recruiting --> Completed | Trial primary completion date: May 2016 --> Nov 2016 N=250 --> 0 | Initiation date: Jan 2016 --> Jan 2017 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jun 2017 --> Jun 2018
- |||||||||| aspirin / Generic mfg.
Trial completion, Enrollment change: Low Dose Aspirin for Venous Leg Ulcers (clinicaltrials.gov) - May 3, 2017 P3, N=251, Completed, No longer recruiting --> Completed Recruiting --> Completed | N=354 --> 251
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers (clinicaltrials.gov) - Apr 19, 2017
P=N/A, N=5, Terminated, Recruiting --> Completed | N=354 --> 251 N=30 --> 5 | Suspended --> Terminated | Trial primary completion date: Aug 2017 --> Nov 2014; TRS probe performance does not meet primary outcome data requirements
- |||||||||| Trial primary completion date: LeucoPatch in the Management of Hard-to-heal Diabetic Foot Ulcers (clinicaltrials.gov) - Apr 19, 2017
P4, N=250, Recruiting, N=30 --> 5 | Suspended --> Terminated | Trial primary completion date: Aug 2017 --> Nov 2014; TRS probe performance does not meet primary outcome data requirements Trial primary completion date: Feb 2017 --> Nov 2017
- |||||||||| Trial completion, Enrollment change: Non-Invasive Assessment of Wound Healing With Optical Methods (clinicaltrials.gov) - Mar 30, 2017
P=N/A, N=38, Completed, Active, not recruiting --> Completed | N=20 --> 24 | Trial primary completion date: Dec 2015 --> Apr 2015 Recruiting --> Completed | N=100 --> 38
- |||||||||| Trial primary completion date: Use of dHACM in the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Mar 23, 2017
P=N/A, N=120, Active, not recruiting, Recruiting --> Completed | N=100 --> 38 Trial primary completion date: Feb 2017 --> Jun 2017
|